SEC Form 4 · accession 0001209191-18-033101
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacques Gonella
Director
Period of report
May 22, 2018
Accepted (ET)
May 24, 2018 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 22, 2018 | S | 5,318 | $2.53 | D | 11,160,033 | D | |
| Common StockF1 | May 23, 2018 | S | 94,682 | $2.53 | D | 11,065,351 | D | |
| Common StockF1 | May 23, 2018 | S | 100,000 | $2.50 | D | 10,965,351 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of common stock reported in this Form 4 was made for estate planning purposes.